Re: Bio Buyouts I would argue that a more reasonable number to put up for IDEV would be $5.4 a share (where the market has generally valued it). That would be a 74% premium. Yes, I know this makes the process somewhat fuzzy, but clearly more accurate. Especially given the fact and investor can cash out at that number. I imagine several others have the same issue.